| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1032.18/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18 |
| Version | 20240606 |
| Status | active |
| Date | 2024-06-06T01:23:01-04:00 |
| Name | HighIntensityStatinTherapyBranded |
| Title | High Intensity Statin Therapy/Branded |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The intent of this value set is to represent SBD and BPCK high intensity statin medications as defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.),(Data Element Scope: RxNorm SBD and BPCK high intensity statin medications as defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.),(Inclusion Criteria: Semantic branded drugs (SBD) and semantic branded drug packs (BPCK) codes that represent high intensity statin medications defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol, along with medications that include simvastatin 80 mg, as that exceeds the dosage threshold for moderate intensity (20-40 mg) and low intensity (10 mg) simvastatin medications.),(Exclusion Criteria: Semantic clinical drugs (SCD) and semantic clinical drug packs (GPCK) RxNorm codes that represent high intensity statin medications, along with any RxNorm codes that represent moderate or low intensity statin medications. Liquid statin medications are also excluded (e.g., Simvastatin 4 mg/ml and Simvastatin 8 mg/ml) since the dosage is not specific.) |
No resources found
| CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm  | RxNorm |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1032.18",
"meta" : {
"versionId" : "20",
"lastUpdated" : "2024-08-26T16:46:29.000-04:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "AHRQ CDS Connect Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-06-06"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-06-06"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1032.18"
}
],
"version" : "20240606",
"name" : "HighIntensityStatinTherapyBranded",
"title" : "High Intensity Statin Therapy/Branded",
"status" : "active",
"date" : "2024-06-06T01:23:01-04:00",
"publisher" : "AHRQ CDS Connect Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The intent of this value set is to represent SBD and BPCK high intensity statin medications as defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.),(Data Element Scope: RxNorm SBD and BPCK high intensity statin medications as defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.),(Inclusion Criteria: Semantic branded drugs (SBD) and semantic branded drug packs (BPCK) codes that represent high intensity statin medications defined by the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol, along with medications that include simvastatin 80 mg, as that exceeds the dosage threshold for moderate intensity (20-40 mg) and low intensity (10 mg) simvastatin medications.),(Exclusion Criteria: Semantic clinical drugs (SCD) and semantic clinical drug packs (GPCK) RxNorm codes that represent high intensity statin medications, along with any RxNorm codes that represent moderate or low intensity statin medications. Liquid statin medications are also excluded (e.g., Simvastatin 4 mg/ml and Simvastatin 8 mg/ml) since the dosage is not specific.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1245449",
"display" : "ezetimibe 10 MG / simvastatin 80 MG Oral Tablet [Vytorin]"
},
{
"code" : "262095",
"display" : "atorvastatin 80 MG Oral Tablet [Lipitor]"
},
{
"code" : "617320",
"display" : "atorvastatin 40 MG Oral Tablet [Lipitor]"
},
{
"code" : "750207",
"display" : "amlodipine 10 MG / atorvastatin 40 MG Oral Tablet [Caduet]"
},
{
"code" : "750211",
"display" : "amlodipine 10 MG / atorvastatin 80 MG Oral Tablet [Caduet]"
},
{
"code" : "750215",
"display" : "amlodipine 2.5 MG / atorvastatin 40 MG Oral Tablet [Caduet]"
},
{
"code" : "750235",
"display" : "amlodipine 5 MG / atorvastatin 40 MG Oral Tablet [Caduet]"
},
{
"code" : "750239",
"display" : "amlodipine 5 MG / atorvastatin 80 MG Oral Tablet [Caduet]"
},
{
"code" : "859421",
"display" : "rosuvastatin calcium 40 MG Oral Tablet [Crestor]"
},
{
"code" : "859753",
"display" : "rosuvastatin calcium 20 MG Oral Tablet [Crestor]"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:b3a2aef8-b3d6-4d59-b3d6-d3b57a558421",
"timestamp" : "2024-12-10T04:46:09-05:00",
"total" : 10,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1245449",
"display" : "ezetimibe 10 MG / simvastatin 80 MG Oral Tablet [Vytorin]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "262095",
"display" : "atorvastatin 80 MG Oral Tablet [Lipitor]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "617320",
"display" : "atorvastatin 40 MG Oral Tablet [Lipitor]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "750207",
"display" : "amlodipine 10 MG / atorvastatin 40 MG Oral Tablet [Caduet]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "750211",
"display" : "amlodipine 10 MG / atorvastatin 80 MG Oral Tablet [Caduet]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "750215",
"display" : "amlodipine 2.5 MG / atorvastatin 40 MG Oral Tablet [Caduet]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "750235",
"display" : "amlodipine 5 MG / atorvastatin 40 MG Oral Tablet [Caduet]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "750239",
"display" : "amlodipine 5 MG / atorvastatin 80 MG Oral Tablet [Caduet]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "859421",
"display" : "rosuvastatin calcium 40 MG Oral Tablet [Crestor]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "859753",
"display" : "rosuvastatin calcium 20 MG Oral Tablet [Crestor]"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.